Breaking News Instant updates and real-time market news.

GILD

Gilead

$73.56 /

+1.25 (+1.73%)

16:05
05/20/20
05/20
16:05
05/20/20
16:05

Gilead's Filgotinib 200mg achieved all primary endpoint in ph2b/3 trial in UC

Gilead (GILD) and Galapagos NV (GLPG) announced positive topline results from SELECTION, a randomized, double-blind, placebo-controlled, Phase 2b/3 trial evaluating the efficacy and safety of the investigational, oral, once-daily, selective JAK1 inhibitor filgotinib in 1,348 biologic-naive or biologic-experienced adult patients with moderately to severely active ulcerative colitis, or UC. Filgotinib 200 mg achieved all primary endpoints in the study, inducing clinical remission at Week 10 and maintaining clinical remission at Week 58 in a significantly higher proportion of patients compared with placebo. Filgotinib 100 mg did not achieve statistically significant clinical remission at Week 10. Among biologic-naive patients, a statistically significant higher proportion of patients achieved clinical remission at Week 10 when treated with filgotinib 200 mg compared with placebo. Among biologic-experienced patients, a statistically significant higher proportion of patients achieved clinical remission at Week 10 when treated with filgotinib 200 mg compared with placebo (4.2 percent). Patients who achieved clinical response or remission after 10 weeks of treatment with filgotinib 100 mg or 200 mg were subsequently re-randomized to their induction dose of filgotinib or placebo in a 2:1 ratio and treated through Week 58 (maintenance trial, n=558). Both doses of filgotinib achieved the primary endpoint in this maintenance trial. At Week 58, 37.2 percent of biologic-naive and biologic-experienced patients receiving filgotinib 200 mg achieved clinical remission, compared with 11.2 percent treated with placebo. Of patients receiving filgotinib 100 mg, 23.8 percent achieved clinical remission at Week 58, compared with 13.5 percent treated with placebo.

  • 20

    May

  • 26

    May

  • 29

    May

  • 10

    Aug

GILD Gilead
$73.56 /

+1.25 (+1.73%)

05/13/20 Piper Sandler
KOL sees remdesivir as COVID-19 standard of care, says Piper Sandler
05/13/20 JPMorgan
Gilead already given 'ample market credit' for remdesivir, says JPMorgan
05/11/20 RBC Capital
Gilead's U.S. remdesivir supply to be 'severely constrained', says RBC Capital
05/06/20 Goldman Sachs
Goldman says Novo Nordisk NASH data a 'clear positive' for Intercept

TODAY'S FREE FLY STORIES

General news
Treasury Market Summary » 17:00
06/05/20
06/05
17:00
06/05/20
17:00

Treasury Market Summary:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Syndicate
Ballard Power files $750M mixed securities shelf  16:59
06/05/20
06/05
16:59
06/05/20
16:59
BLDP

Ballard Power

$12.09 /

+0.15 (+1.26%)

 
ShowHide Related Items >><<
BLDP Ballard Power
$12.09 /

+0.15 (+1.26%)

BLDP Ballard Power
$12.09 /

+0.15 (+1.26%)

03/10/20 H.C. Wainwright
Ballard Power upgraded to Buy from Neutral at H.C. Wainwright
03/06/20 Lake Street
Ballard Power price target raised to $13 from $6 at Lake Street
03/06/20 Roth Capital
Ballard Power upgraded to Neutral from Sell at Roth Capital
11/01/19 Lake Street
Ballard Power price target raised to $6 from $5 at Lake Street
BLDP Ballard Power
$12.09 /

+0.15 (+1.26%)

BLDP Ballard Power
$12.09 /

+0.15 (+1.26%)

Hot Stocks
CACI CEO sells over 5,000 common shares » 16:50
06/05/20
06/05
16:50
06/05/20
16:50
CACI

CACI

$254.07 /

-7.41 (-2.83%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CACI CACI
$254.07 /

-7.41 (-2.83%)

CACI CACI
$254.07 /

-7.41 (-2.83%)

05/04/20 Wells Fargo
Leidos price target raised to $114 from $105 at Wells Fargo
04/20/20 Citi
CACI upgraded to Buy from Neutral at Citi
04/02/20 Wells Fargo
CACI price target lowered to $280 from $310 at Wells Fargo
03/30/20 William Blair
CACI initiated with an Outperform at William Blair
CACI CACI
$254.07 /

-7.41 (-2.83%)

CACI CACI
$254.07 /

-7.41 (-2.83%)

Hot Stocks
Adage Capial reports 5.64% passive stake in CommScope » 16:49
06/05/20
06/05
16:49
06/05/20
16:49
COMM

CommScope

$10.99 /

+0.7 (+6.80%)

Adage Capial disclosed a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COMM CommScope
$10.99 /

+0.7 (+6.80%)

COMM CommScope
$10.99 /

+0.7 (+6.80%)

05/05/20
Fly Intel: Top five analyst initiations
05/05/20 Loop Capital
CommScope initiated with a Hold at Loop Capital
05/05/20 Loop Capital
CommScope initiated with a Hold at Loop Capital
04/20/20 JPMorgan
JPMorgan downgrades CommScope on limited EBITDA growth potential
COMM CommScope
$10.99 /

+0.7 (+6.80%)

COMM CommScope
$10.99 /

+0.7 (+6.80%)

Hot Stocks
Allegiant Travel CEO sells 165K shares of common stock » 16:45
06/05/20
06/05
16:45
06/05/20
16:45
ALGT

Allegiant Travel

$124.09 /

-1.59 (-1.27%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALGT Allegiant Travel
$124.09 /

-1.59 (-1.27%)

ALGT Allegiant Travel
$124.09 /

-1.59 (-1.27%)

05/13/20 Raymond James
Spirit Airlines downgraded to Market Perform from Outperform at Raymond James
05/13/20 Raymond James
Allegiant Travel upgraded to Outperform from Market Perform at Raymond James
05/13/20 Raymond James
Allegiant Travel upgraded to Outperform from Market Perform at Raymond James
05/04/20 Barclays
Barclays downgrades U.S. Airlines sector along with American and Delta
ALGT Allegiant Travel
$124.09 /

-1.59 (-1.27%)

ALGT Allegiant Travel
$124.09 /

-1.59 (-1.27%)

ALGT Allegiant Travel
$124.09 /

-1.59 (-1.27%)

ALGT Allegiant Travel
$124.09 /

-1.59 (-1.27%)

Conference/Events
Cincinnati Financial management to meet with Piper Sandler » 16:43
06/05/20
06/05
16:43
06/05/20
16:43
CINF

Cincinnati Financial

$68.76 /

+4.14 (+6.41%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CINF Cincinnati Financial
$68.76 /

+4.14 (+6.41%)

CINF Cincinnati Financial
$68.76 /

+4.14 (+6.41%)

06/03/20 RBC Capital
Cincinnati Financial upgraded to Outperform from Sector Perform at RBC Capital
06/03/20 RBC Capital
Cincinnati Financial upgraded to Outperform from Sector Perform at RBC Capital
05/06/20 Credit Suisse
Cincinnati Financial downgraded to Underperform from Neutral at Credit Suisse
04/30/20 Keefe Bruyette
Cincinnati Financial price target lowered to $72 from $81 at Keefe Bruyette
CINF Cincinnati Financial
$68.76 /

+4.14 (+6.41%)

CINF Cincinnati Financial
$68.76 /

+4.14 (+6.41%)

Conference/Events
Independent Bank management to virtually meet with Piper Sandler » 16:40
06/05/20
06/05
16:40
06/05/20
16:40
IBTX

Independent Bank

$42.86 /

+3.6 (+9.17%)

Virtual meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IBTX Independent Bank
$42.86 /

+3.6 (+9.17%)

IBTX Independent Bank
$42.86 /

+3.6 (+9.17%)

06/02/20 Jefferies
Texas Capital resumed with a Hold at Jefferies
05/26/20 Raymond James
Independent Bank upgraded to Outperform from Market Perform at Raymond James
05/26/20 Raymond James
Independent Bank upgraded to Outperform from Market Perform at Raymond James
05/26/20 Keefe Bruyette
Texas Capital downgraded to Market Perform from Outperform at Keefe Bruyette
IBTX Independent Bank
$42.86 /

+3.6 (+9.17%)

IBTX Independent Bank
$42.86 /

+3.6 (+9.17%)

Hot Stocks
Emergent BioSolutions' Richard sells 6,572 common shares » 16:39
06/05/20
06/05
16:39
06/05/20
16:39
EBS

Emergent BioSolutions

$86.87 /

+2.13 (+2.51%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EBS Emergent BioSolutions
$86.87 /

+2.13 (+2.51%)

EBS Emergent BioSolutions
$86.87 /

+2.13 (+2.51%)

06/02/20 Guggenheim
Emergent BioSolutions price target raised to $101 from $81 at Guggenheim
02/25/20 Wells Fargo
Emergent BioSolutions price target raised to $75 from $66 at Wells Fargo
01/22/20 Wells Fargo
Revance, Amphastar named top 2020 Specialty Pharmaceuticals ideas at Wells Fargo
01/08/20 Guggenheim
Horizon Therapeutics named Guggenheim's best Emerging Pharma idea for 2020
EBS Emergent BioSolutions
$86.87 /

+2.13 (+2.51%)

EBS Emergent BioSolutions
$86.87 /

+2.13 (+2.51%)

Hot Stocks
ValueAct reports 7.5% stake in Enviva Partners, says shares undervalued » 16:36
06/05/20
06/05
16:36
06/05/20
16:36
EVA

Enviva

$34.85 /

+0.575 (+1.68%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EVA Enviva
$34.85 /

+0.575 (+1.68%)

EVA Enviva
$34.85 /

+0.575 (+1.68%)

04/24/20 Citi
Enviva price target lowered to $35 from $40 at Citi
03/18/20 Raymond James
Enviva entry point is 'compelling,' says Raymond James
03/18/20 Raymond James
Enviva upgraded to Strong Buy from Outperform at Raymond James
02/13/20 Citi
Enviva downgraded to Neutral from Buy at Citi
EVA Enviva
$34.85 /

+0.575 (+1.68%)

Hot Stocks
GSE Systems discloses notice of Nasdaq listing non-compliance » 16:33
06/05/20
06/05
16:33
06/05/20
16:33
GVP

GSE Systems

$1.20 /

+0.06 (+5.26%)

GSE Systems announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GVP GSE Systems
$1.20 /

+0.06 (+5.26%)

Hot Stocks
TopBuild CEO sells 50,000 common shares » 16:33
06/05/20
06/05
16:33
06/05/20
16:33
BLD

TopBuild

$130.53 /

+8.785 (+7.22%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BLD TopBuild
$130.53 /

+8.785 (+7.22%)

BLD TopBuild
$130.53 /

+8.785 (+7.22%)

05/27/20 Credit Suisse
TopBuild initiated with an Outperform at Credit Suisse
05/27/20 Nomura Instinet
TopBuild price target raised to $114 from $104 at Nomura Instinet
05/06/20 SunTrust
TopBuild price target raised to $110 from $90 at SunTrust
05/06/20 Deutsche Bank
TopBuild price target raised to $113 from $103 at Deutsche Bank
BLD TopBuild
$130.53 /

+8.785 (+7.22%)

Hot Stocks
Yatra terminates merger agreement with Ebix, files litigation » 16:33
06/05/20
06/05
16:33
06/05/20
16:33
YTRA

Yatra

$1.50 /

+0.24 (+19.05%)

, EBIX

Ebix

$28.32 /

+1.25 (+4.62%)

Yatra (YTRA) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
YTRA Yatra
$1.50 /

+0.24 (+19.05%)

EBIX Ebix
$28.32 /

+1.25 (+4.62%)

YTRA Yatra
$1.50 /

+0.24 (+19.05%)

11/13/19 BMO Capital
Ebix price target lowered to $46 from $50 at BMO Capital
EBIX Ebix
$28.32 /

+1.25 (+4.62%)

05/12/20 Craig-Hallum
Ebix shares and estimates 'have put in a floor,' says Craig-Hallum
05/12/20 BMO Capital
Ebix price target lowered to $34 from $43 at BMO Capital
04/30/20 Craig-Hallum
Ebix price target lowered to $75 from $80 at Craig-Hallum
03/26/20 Craig-Hallum
Ebix to be top performer as investors realize stock mispriced, says Craig-Hallum
EBIX Ebix
$28.32 /

+1.25 (+4.62%)

EBIX Ebix
$28.32 /

+1.25 (+4.62%)

Syndicate
Fortive files automatic mixed securities shelf  16:33
06/05/20
06/05
16:33
06/05/20
16:33
FTV

Fortive

$70.61 /

+3.12 (+4.62%)

 
ShowHide Related Items >><<
FTV Fortive
$70.61 /

+3.12 (+4.62%)

FTV Fortive
$70.61 /

+3.12 (+4.62%)

09:00 Today Vertical Research
Fortive upgraded to Buy from Hold at Vertical Research
05/19/20 Morgan Stanley
Fortive resumed with an Overweight at Morgan Stanley
05/06/20 Credit Suisse
Fortive price target lowered to $71 from $85 at Credit Suisse
04/27/20 Citi
Fortive reinstated with a Buy at Citi
FTV Fortive
$70.61 /

+3.12 (+4.62%)

FTV Fortive
$70.61 /

+3.12 (+4.62%)

FTV Fortive
$70.61 /

+3.12 (+4.62%)

Syndicate
Citius Pharmaceuticals files to sell 4.02M shares of common stock for holders  16:32
06/05/20
06/05
16:32
06/05/20
16:32
CTXR

Citius Pharmaceuticals

$0.95 /

-0.0015 (-0.16%)

 
ShowHide Related Items >><<
CTXR Citius Pharmaceuticals
$0.95 /

-0.0015 (-0.16%)

Syndicate
Intec Pharma files to sell 8.15M shares of common stock for holders  16:31
06/05/20
06/05
16:31
06/05/20
16:31
NTEC

Intec Pharma

$0.38 /

-0.0424 (-10.14%)

 
ShowHide Related Items >><<
NTEC Intec Pharma
$0.38 /

-0.0424 (-10.14%)

NTEC Intec Pharma
$0.38 /

-0.0424 (-10.14%)

11/14/19 Roth Capital
Intec Pharma may pursue partnership after failed trial, says Roth Capital
10/11/19 Roth Capital
Intec Pharma downgraded to Neutral from Buy at Roth Capital
08/07/19 H.C. Wainwright
Intec Pharma downgraded to Neutral from Buy at H.C. Wainwright
07/22/19 Ladenburg
Intec Pharma downgraded to Neutral from Buy at Ladenburg
NTEC Intec Pharma
$0.38 /

-0.0424 (-10.14%)

Hot Stocks
GAIN Capital stockholders approver merger with INTL FCStone » 16:31
06/05/20
06/05
16:31
06/05/20
16:31
GCAP

Gain Capital

$6.11 /

-0.005 (-0.08%)

GAIN Capital Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GCAP Gain Capital
$6.11 /

-0.005 (-0.08%)

GCAP Gain Capital
$6.11 /

-0.005 (-0.08%)

02/28/20 JPMorgan
Gain Capital downgraded to Neutral from Overweight at JPMorgan
09/18/19 B. Riley FBR
B. Riley FBR starts 'extremely undervalued' Gain Capital with Buy rating
09/18/19 B. Riley FBR
Gain Capital initiated with a Buy at B. Riley FBR
08/15/19
Fly Intel: Top five analyst upgrades
GCAP Gain Capital
$6.11 /

-0.005 (-0.08%)

Options
Preliminary option volume of 46.7M today » 16:30
06/05/20
06/05
16:30
06/05/20
16:30

Preliminary option volume…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Syndicate
Achieve Life Sciences files to sell 10.33M shares of common stock for holders  16:23
06/05/20
06/05
16:23
06/05/20
16:23
ACHV

Achieve Life Sciences

$0.47 /

+0.022 (+4.91%)

 
ShowHide Related Items >><<
ACHV Achieve Life Sciences
$0.47 /

+0.022 (+4.91%)

ACHV Achieve Life Sciences
$0.47 /

+0.022 (+4.91%)

02/25/20 H.C. Wainwright
Achieve Life Sciences initiated with a Buy at H.C. Wainwright
06/14/19 Maxim
Achieve Life Sciences initiated with a Buy at Maxim
06/14/19 Maxim
Achieve Life Sciences initiated with a Buy at Maxim
06/11/19 Ladenburg
Achieve Life Sciences price target raised to $20 from $12 at Ladenburg
ACHV Achieve Life Sciences
$0.47 /

+0.022 (+4.91%)

Syndicate
Kadmon files $300M mixed securities shelf  16:21
06/05/20
06/05
16:21
06/05/20
16:21
KDMN

Kadmon

$4.48 /

+0.115 (+2.64%)

 
ShowHide Related Items >><<
KDMN Kadmon
$4.48 /

+0.115 (+2.64%)

KDMN Kadmon
$4.48 /

+0.115 (+2.64%)

05/19/20 Raymond James
Kadmon initiated with an Outperform at Raymond Jame
05/19/20 Raymond James
Kadmon initiated with an Outperform at Raymond James
03/16/20 Nomura Instinet
Kadmon news of FDA meeting a positive, says Nomura Instinet
01/10/20 Nomura Instinet
Kadmon initiated with a Buy at Nomura Instinet
KDMN Kadmon
$4.48 /

+0.115 (+2.64%)

KDMN Kadmon
$4.48 /

+0.115 (+2.64%)

Options
Closing CBOE SPX and VIX Index summary for June 5th » 16:20
06/05/20
06/05
16:20
06/05/20
16:20
VIX

Volatility Index S&P 500 Options

$0.00 /

+ (+0.00%)

The CBOE Volatility Index…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VIX Volatility Index S&P 500 Options
$0.00 /

+ (+0.00%)

Hot Stocks
DavidsTea extends filing deadline for Q1 results to 'no later than July 31st' » 16:19
06/05/20
06/05
16:19
06/05/20
16:19
DTEA

DavidsTea

$1.36 /

-0.06 (-4.23%)

DAVIDsTEA announces that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DTEA DavidsTea
$1.36 /

-0.06 (-4.23%)

DTEA DavidsTea
$1.36 /

-0.06 (-4.23%)

Hot Stocks
AgeX Therapeutics receives noncompliance notification from NYSE » 16:18
06/05/20
06/05
16:18
06/05/20
16:18
AGE

AgeX Therapeutics

$0.89 /

+0.0002 (+0.02%)

AgeX Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AGE AgeX Therapeutics
$0.89 /

+0.0002 (+0.02%)

Technical Analysis
On The Fly: Weekly technical notes for Russell 2000 » 16:17
06/05/20
06/05
16:17
06/05/20
16:17
RUT

Russell 2000 Index

$0.00 /

+ (+0.00%)

, IWM

iShares Trust Russell 2000 Index Fund

$150.21 /

+5.59 (+3.87%)

At time of writing the…

At time of writing the Russell 2000 (RUT) was settling close to the 1500 area, following a huge one-day push higher to cap a winning week. The resistance range will be 1515-1550 for the coming week. Support will be at 1500-1450. Basic Materials, Consumer Discretionary, Energy, Industrials, and the Financials were the leading groups. Health Care and Utilities were laggards.

ShowHide Related Items >><<
RUT Russell 2000 Index
$0.00 /

+ (+0.00%)

IWM iShares Trust Russell 2000 Index Fund
$150.21 /

+5.59 (+3.87%)

RUT Russell 2000 Index
$0.00 /

+ (+0.00%)

IWM iShares Trust Russell 2000 Index Fund
$150.21 /

+5.59 (+3.87%)

Technical Analysis
NASDAQ market internals summary » 16:17
06/05/20
06/05
16:17
06/05/20
16:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume was above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Syndicate
Kadmon raises $50M from At-The-Market facility » 16:17
06/05/20
06/05
16:17
06/05/20
16:17
KDMN

Kadmon

$4.48 /

+0.115 (+2.64%)

Kadmon announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KDMN Kadmon
$4.48 /

+0.115 (+2.64%)

KDMN Kadmon
$4.48 /

+0.115 (+2.64%)

05/19/20 Raymond James
Kadmon initiated with an Outperform at Raymond Jame
05/19/20 Raymond James
Kadmon initiated with an Outperform at Raymond James
03/16/20 Nomura Instinet
Kadmon news of FDA meeting a positive, says Nomura Instinet
01/10/20 Nomura Instinet
Kadmon initiated with a Buy at Nomura Instinet
KDMN Kadmon
$4.48 /

+0.115 (+2.64%)

KDMN Kadmon
$4.48 /

+0.115 (+2.64%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.